These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 23880115)

  • 1. Younger age at diagnosis is associated with panenteric, but not more aggressive, Crohn's disease.
    Israeli E; Ryan JD; Shafer LA; Bernstein CN
    Clin Gastroenterol Hepatol; 2014 Jan; 12(1):72-79.e1. PubMed ID: 23880115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.
    Gologan S; Iacob R; Preda C; Vadan R; Cotruta B; Catuneanu AM; Iacob S; Constantinescu I; Gheorghe L; Iobagiu S; Gheorghe C; Diculescu M
    J Gastrointestin Liver Dis; 2012 Mar; 21(1):39-44. PubMed ID: 22457858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic yield of upper endoscopy in paediatric patients with Crohn's disease and ulcerative colitis. Subanalysis of the HUPIR registry.
    Kovacs M; Muller KE; Arato A; Lakatos PL; Kovacs JB; Varkonyi A; Solyom E; Polgar M; Nemes E; Guthy I; Tokodi I; Toth G; Horvath A; Tarnok A; Tomsits E; Csoszánszky N; Balogh M; Vass N; Bodi P; Dezsofi A; Gardos L; Micskey E; Papp M; Szucs D; Cseh A; Molnar K; Szabo D; Veres G;
    J Crohns Colitis; 2012 Feb; 6(1):86-94. PubMed ID: 22261532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic features of Crohn's disease associated with failure of medical treatment.
    Moran GW; Dubeau MF; Kaplan GG; Yang H; Seow CH; Fedorak RN; Dieleman LA; Barkema HW; Ghosh S; Panaccione R;
    Clin Gastroenterol Hepatol; 2014 Mar; 12(3):434-42.e1. PubMed ID: 23978351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and risk factors for primary surgery in 205 patients with Crohn's disease: analysis of a South China cohort.
    Song XM; Gao X; Li MZ; Chen ZH; Chen SC; Hu PJ; He YL; Zhan WH; Chen MH
    Dis Colon Rectum; 2011 Sep; 54(9):1147-54. PubMed ID: 21825896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, outcomes, and health services burden of very early onset inflammatory bowel disease.
    Benchimol EI; Mack DR; Nguyen GC; Snapper SB; Li W; Mojaverian N; Quach P; Muise AM
    Gastroenterology; 2014 Oct; 147(4):803-813.e7; quiz e14-5. PubMed ID: 24951840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of the Porto criteria for the diagnosis of paediatric inflammatory bowel disease in a paediatric reference centre].
    Martín de Carpi J; Vila V; Varea V
    An Pediatr (Barc); 2011 Oct; 75(4):232-8. PubMed ID: 21549650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of esophagogastroduodenoscopy in the initial assessment of children with inflammatory bowel disease.
    Lemberg DA; Clarkson CM; Bohane TD; Day AS
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1696-700. PubMed ID: 16246188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perianal disease predicts changes in Crohn's disease phenotype-results of a population-based study of inflammatory bowel disease phenotype.
    Tarrant KM; Barclay ML; Frampton CM; Gearry RB
    Am J Gastroenterol; 2008 Dec; 103(12):3082-93. PubMed ID: 19086959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease.
    Romberg-Camps MJ; Dagnelie PC; Kester AD; Hesselink-van de Kruijs MA; Cilissen M; Engels LG; Van Deursen C; Hameeteman WH; Wolters FL; Russel MG; Stockbrügger RW
    Am J Gastroenterol; 2009 Feb; 104(2):371-83. PubMed ID: 19174787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project.
    Cleynen I; González JR; Figueroa C; Franke A; McGovern D; Bortlík M; Crusius BJ; Vecchi M; Artieda M; Szczypiorska M; Bethge J; Arteta D; Ayala E; Danese S; van Hogezand RA; Panés J; Peña SA; Lukas M; Jewell DP; Schreiber S; Vermeire S; Sans M
    Gut; 2013 Nov; 62(11):1556-65. PubMed ID: 23263249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease.
    Van Limbergen J; Russell RK; Drummond HE; Aldhous MC; Round NK; Nimmo ER; Smith L; Gillett PM; McGrogan P; Weaver LT; Bisset WM; Mahdi G; Arnott ID; Satsangi J; Wilson DC
    Gastroenterology; 2008 Oct; 135(4):1114-22. PubMed ID: 18725221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease phenotype at diagnosis in pediatric Crohn's disease: 5-year analyses of the EUROKIDS Registry.
    de Bie CI; Paerregaard A; Kolacek S; Ruemmele FM; Koletzko S; Fell JM; Escher JC;
    Inflamm Bowel Dis; 2013 Feb; 19(2):378-85. PubMed ID: 22573581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of frequency, clinical course and treatment of Crohn's disease based upon the own material and experience].
    Czkwianianc E; Kolasa-Kicińska M; Trojanowska-Lipczyk J; Makosiej R; Malecka-Panas E
    Pol Merkur Lekarski; 2009 May; 26(155):446-51. PubMed ID: 19606694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
    Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS
    Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical aspects of Crohn's disease of the upper gastrointestinal tract: a comparison with distal Crohn's disease.
    Wagtmans MJ; Verspaget HW; Lamers CB; van Hogezand RA
    Am J Gastroenterol; 1997 Sep; 92(9):1467-71. PubMed ID: 9317064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory bowel diseases: controversies in the use of diagnostic procedures.
    Vucelic B
    Dig Dis; 2009; 27(3):269-77. PubMed ID: 19786751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spectrum of perianal Crohn's disease in a population-based cohort.
    Eglinton TW; Barclay ML; Gearry RB; Frizelle FA
    Dis Colon Rectum; 2012 Jul; 55(7):773-7. PubMed ID: 22706129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.